That investment should be protected in order to stimulate research and innovation, in particular on veterinary medicinal products for minor species and antimicrobials, so that it is ensured that the necessary veterinary medicinal products are available in the Union.
Ba cheart an infheistíocht sin a chosaint chun taighde agus nuálaíocht a spreagadh, go háirithe maidir le táirgí íocshláinte tréidliachta do mhionspeicis agus d’ábhair fhrithmhiocróbacha, chun a áirithiú go mbeidh na táirgí íocshláinte tréidliachta is gá ar fáil san Aontas.